Glucocerebroside Treatment Of Liver Disorders

Abstract

The present invention provides a method for the treatment of immune mediated or immune related diseases or disorders, infectious diseases, metabolic disorders and cancer in mammalian subjects. This method comprises the administration of a naturally occurring, mammalian intermediary metabolite or T cell receptor ligand, preferably a glucosylceramide, to a mammalian subject. In a preferred embodiment, such mammalian subjects are human beings.


Claims
Owners (US)

Information currently unavailable.

IPC Classifications
Download PDF
Document Preview
Document History
  • Publication: Mar 6, 2018
  • Application: Jul 12, 2017
    US US 201715647431 A
  • Priority: Jul 12, 2017
    US US 201715647431 A
  • Priority: Mar 17, 2006
    US US 37894106 A
  • Priority: Sep 30, 2003
    US US 67598003 A
  • Priority: Feb 27, 2003
    US US 37590603 A

Download Citation


Sign in to the Lens

Feedback